Research and Markets: Psychosis-Pipeline Insights 2015 - Provides a Psychosis Landscape Overview Across the Globe

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/8mwx6g/psychosispipeline) has announced the addition of the "Psychosis-Pipeline Insights" report to their offering.

Psychosis- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Psychosis. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Psychosis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Psychosis- Pipeline Insights Report covers the Psychosis pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Psychosis related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Psychosis.

Scope

  • The report provides a Psychosis Landscape across the globe
  • The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information
  • Coverage of the Psychosis pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Psychosis and also provide company profiling

Key Topics Covered:

  • Psychosis Overview
  • Psychosis Pipeline Therapeutics
  • Psychosis Therapeutics under Development by Companies
  • Psychosis Late Stage Products (Filed and Phase III)
  • Comparative Analysis
  • Psychosis Mid Clinical Stage Products (Phase II)
  • Comparative Analysis
  • Psychosis Early Clinical Stage Products (Phase I and IND Filed)
  • Comparative Analysis
  • Psychosis Discovery and Pre-Clinical Stage Products
  • Comparative Analysis
  • Drug Candidate Profiles
  • Psychosis - Therapeutics Assessment
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Psychosis - Discontinued Products
  • Psychosis - Dormant Products
  • Companies Involved in Therapeutics Development for Psychosis

For more information visit http://www.researchandmarkets.com/research/8mwx6g/psychosispipeline

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals